These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 175286)

  • 1. Receptor-binding region of insulin.
    Pullen RA; Lindsay DG; Wood SP; Tickle IJ; Blundell TL; Wollmer A; Krail G; Brandenburg D; Zahn H; Gliemann J; Gammeltoft S
    Nature; 1976 Feb; 259(5542):369-73. PubMed ID: 175286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation of conformation and association of insulin to receptor binding; x-ray and circular-dichroism studies on bovine and hystricomorph insulins.
    Wood SP; Blundell TL; Wollmer A; Lazarus NR; Neville RW
    Eur J Biochem; 1975 Jul; 55(3):531-42. PubMed ID: 1175610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulin.
    Schwartz GP; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1983 Sep; 22(19):4561-7. PubMed ID: 6354263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function relationships of shortened [LeuB25]insulins, semisynthetic analogues of a mutant human insulin.
    Fischer WH; Saunders D; Brandenburg D; Diaconescu C; Wollmer A; Dodson G; De Meyts P; Zahn H
    Biol Chem Hoppe Seyler; 1986 Sep; 367(9):999-1006. PubMed ID: 3539147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin receptors in fat cells: relationship between binding and activation.
    Gliemann J; Gammeltoft S; Vinten J
    Isr J Med Sci; 1975 Jul; 11(7):656-63. PubMed ID: 169211
    [No Abstract]   [Full Text] [Related]  

  • 6. Polypeptide hormone-receptor interactions: the structure and receptor binding of insulin and glucagon.
    Bedarkar S; Blundell TL; Dockerill S; Tickle IJ; Wood SP
    Ciba Found Symp; 1977; (60):105-21. PubMed ID: 215391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biological activity and the binding affinity of modified insulins determined on isolated rat fat cells.
    Gliemann J; Gammeltoft S
    Diabetologia; 1974 Apr; 10(2):105-13. PubMed ID: 4367434
    [No Abstract]   [Full Text] [Related]  

  • 8. Receptor-binding assay of chemically modified insulins. Comparison with in vitro and in vivo bioassays.
    Freychet P; Brandenburg D; Wollmer A
    Diabetologia; 1974 Feb; 10(1):1-5. PubMed ID: 4365215
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tetrakis(3-nitrotyrosine)]insulin.
    Carpenter FH; Boesel RW; Sakai DD
    Biochemistry; 1980 Dec; 19(25):5926-31. PubMed ID: 7006695
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of N-methylation of selected peptide bonds on the biological activity of insulin. [2-N-methylisoleucine-A]insulin and [3-N-methylvaline-A]insulin.
    Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
    Int J Pept Protein Res; 1987 Oct; 30(4):460-73. PubMed ID: 3323092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of the residues responsible for the negative cooperativity of the receptor-binding region of insulin.
    De Meyts P; Van Obberghen E; Roth J
    Nature; 1978 Jun; 273(5663):504-9. PubMed ID: 661960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone.
    Chu YC; Zong L; Burke GT; Katsoyannis PG
    J Protein Chem; 1992 Oct; 11(5):571-7. PubMed ID: 1360216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence concerning the mechanism of insulin-receptor interaction and the structure of the insulin receptor from biological properties of covalently linked insulin dimers.
    Tatnell MA; Jones RH; Willey KP; Schüttler A; Brandenburg D
    Biochem J; 1983 Dec; 216(3):687-94. PubMed ID: 6365079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural stability in the 4-zinc human insulin hexamer.
    Smith GD; Swenson DC; Dodson EJ; Dodson GG; Reynolds CD
    Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7093-7. PubMed ID: 6390430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of C-terminal B-chain residues in insulin assembly: the structure of hexameric LysB28ProB29-human insulin.
    Ciszak E; Beals JM; Frank BH; Baker JC; Carter ND; Smith GD
    Structure; 1995 Jun; 3(6):615-22. PubMed ID: 8590022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A2-Norleucine]insulin. An analog with unanticipated biological properties.
    Okada Y; Chanley JD; Burke GT; Katsoyannis PG
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):629-38. PubMed ID: 7024085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsuppressible insulin-like activity: biological activity and receptor binding.
    Zapf J; Mäder M; Waldvogel M; Froesch ER
    Isr J Med Sci; 1975 Jul; 11(7):664-78. PubMed ID: 169212
    [No Abstract]   [Full Text] [Related]  

  • 18. A proposed interaction model of the insulin molecule with its receptor.
    Liang DC; Chang WR; Wan ZL
    Biophys Chem; 1994 May; 50(1-2):63-71. PubMed ID: 8011941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions.
    Shoelson SE; Lu ZX; Parlautan L; Lynch CS; Weiss MA
    Biochemistry; 1992 Feb; 31(6):1757-67. PubMed ID: 1737029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray analysis of glucagon and its relationship to receptor binding.
    Sasaki K; Dockerill S; Adamiak DA; Tickle IJ; Blundell T
    Nature; 1975 Oct; 257(5529):751-7. PubMed ID: 171582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.